{"id":45869,"date":"2022-07-06T17:01:41","date_gmt":"2022-07-06T15:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/"},"modified":"2022-07-06T17:01:41","modified_gmt":"2022-07-06T15:01:41","slug":"global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/","title":{"rendered":"Global Food Allergy Market Report to 2032 &#8211; Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5574389\/food-allergy-market-insight-epidemiology-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sx6stq&amp;utm_campaign=1722415+-+Global+Food+Allergy+Market+Report+to+2032+-+Featuring+Aimmune+Therapeutics%2C+Novartis+Pharmaceuticals+and+DBV+Technologies+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Food Allergy &#8211; Market Insight, Epidemiology and Market Forecast &#8211; 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, Canada and China.\n<\/p>\n<p>\nThe Food Allergy market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted Food Allergy symptoms market size from 2019 to 2032 segmented by nine major markets. The report also covers current Food Allergy symptoms treatment practice\/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAimmune Therapeutics, Inc.\n<\/li>\n<li>\nNovartis Pharmaceuticals\n<\/li>\n<li>\nDBV Technologies\n<\/li>\n<li>\nInnoUp Farma S.L.\n<\/li>\n<li>\nCOUR Pharmaceutical Development Company Inc.\n<\/li>\n<li>\nVedanta Biosciences, Inc.\n<\/li>\n<li>\nRegeneron Pharmaceuticals\n<\/li>\n<li>\nGenentech, Inc.\n<\/li>\n<li>\nRho Federal Systems Division, Inc.\n<\/li>\n<li>\nAlladapt Immunotherapeutics, Inc.\n<\/li>\n<li>\nCamallergy\n<\/li>\n<\/ul>\n<p>\n<strong>Geographies Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nChina\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>KOL Views<\/strong>\n<\/p>\n<p>\nTo keep up with current market trends, we take KOLs and SME&#8217;s opinion working Food Allergy domain through primary research to fill the data gaps and validate our secondary research. Their opinions help understand and validate current and emerging therapies treatment patterns or Food Allergy market trends. This will support the clients in potential upcoming novel treatment by identifying the market&#8217;s overall scenario and the unmet needs.\n<\/p>\n<p>\n<strong>Competitive Intelligence Analysis<\/strong>\n<\/p>\n<p>\nThe publisher performs a Competitive and Market Intelligence analysis of the Food Allergy Market by using various Competitive Intelligence tools: SWOT analysis, PESTLE analysis, Porter&#8217;s five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe report covers the descriptive overview of Food Allergy explaining its causes, signs and symptoms, pathophysiology, and currently available therapies\n<\/li>\n<li>\nComprehensive insight has been provided into the Food Allergy epidemiology and treatment in the 7MM, Canada and China\n<\/li>\n<li>\nAdditionally, an all-inclusive account of both the current and emerging therapies for Food Allergy is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape\n<\/li>\n<li>\nA detailed review of Food Allergy market; historical and forecasted is included in the report, covering drug outreach in the 7MM, Canada and China\n<\/li>\n<li>\nThe report provides an edge while developing business strategies by understanding trends shaping and driving the global Food Allergy market\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nIn the coming years, Food Allergy market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market\n<\/li>\n<li>\nThe companies and academics are working to assess challenges and seek opportunities that could influence Food Allergy R&amp;D. The therapies under development are focused on novel approaches to treat\/improve the disease condition\n<\/li>\n<li>\nMajor players are involved in developing therapies for Food Allergy. The launch of emerging therapies will significantly impact the Food Allergy market\n<\/li>\n<li>\nA better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Food Allergy\n<\/li>\n<li>\nOur in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities\n<\/li>\n<\/ul>\n<p>\n<strong>Food Allergy Report Insights<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Population\n<\/li>\n<li>\nTherapeutic Approaches\n<\/li>\n<li>\nFood Allergy Pipeline Analysis\n<\/li>\n<li>\nFood Allergy Market Size and Trends\n<\/li>\n<li>\nMarket Opportunities\n<\/li>\n<li>\nImpact of upcoming Therapies\n<\/li>\n<\/ul>\n<p>\n<strong>Food Allergy Report Key Strengths<\/strong>\n<\/p>\n<ul>\n<li>\n11 Years Forecast\n<\/li>\n<li>\n7MM, Canada and China Coverage\n<\/li>\n<li>\nFood Allergy Epidemiology Segmentation\n<\/li>\n<li>\nKey Cross Competition\n<\/li>\n<li>\nHighly Analyzed Market\n<\/li>\n<li>\nDrugs Uptake\n<\/li>\n<\/ul>\n<p>\n<strong>Food Allergy Report Assessment<\/strong>\n<\/p>\n<ul>\n<li>\nCurrent Treatment Practices\n<\/li>\n<li>\nUnmet Needs\n<\/li>\n<li>\nPipeline Product Profiles\n<\/li>\n<li>\nMarket Attractiveness\n<\/li>\n<li>\nMarket Drivers and Barriers\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nThe report will help in developing business strategies by understanding trends shaping and driving the Food Allergy market\n<\/li>\n<li>\nTo understand the future market competition in the Food Allergy market and Insightful review of the key market drivers and barriers\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for Food Allergy in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), Japan, Canada and China\n<\/li>\n<li>\nIdentification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for Food Allergy market\n<\/li>\n<li>\nTo understand the future market competition in the Food Allergy market\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5574389\/food-allergy-market-insight-epidemiology-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sx6stq&amp;utm_campaign=1722415+-+Global+Food+Allergy+Market+Report+to+2032+-+Featuring+Aimmune+Therapeutics%2C+Novartis+Pharmaceuticals+and+DBV+Technologies+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/6b8945<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;&#x65;s&#115;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;h&#97;&#x6e;&#x64;&#109;&#97;&#x72;k&#101;&#x74;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#x65;&#115;&#x65;&#x61;&#114;c&#x68;&#97;n&#x64;&#x6d;&#97;&#x72;&#x6b;&#101;t&#x73;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Food Allergy &#8211; Market Insight, Epidemiology and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, Canada and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45869","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Food Allergy &#8211; Market Insight, Epidemiology and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, Canada and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-06T15:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Food Allergy Market Report to 2032 &#8211; Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-06T15:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/\"},\"wordCount\":856,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005626\\\/en\\\/1506045\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005626\\\/en\\\/1506045\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-06T15:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005626\\\/en\\\/1506045\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005626\\\/en\\\/1506045\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Food Allergy Market Report to 2032 &#8211; Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Food Allergy &#8211; Market Insight, Epidemiology and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, Canada and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-06T15:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Food Allergy Market Report to 2032 &#8211; Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-06T15:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/"},"wordCount":856,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/","name":"Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg","datePublished":"2022-07-06T15:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220706005626\/en\/1506045\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-food-allergy-market-report-to-2032-featuring-aimmune-therapeutics-novartis-pharmaceuticals-and-dbv-technologies-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Food Allergy Market Report to 2032 &#8211; Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45869"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45869\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}